A U.S. based generic pharmaceutical company approached Freyr to close their Regulatory 17 audit findings (Nine 483s). Freyr had just two calendar days to send the CAPA with RCA. With challenges around, Freyr’s GMP audit team was able to complete the review of the audit report and gave appropriate responses in a short span of time.
Find out the various solutions Freyr offered to the client and how the client was benefitted? Read the case study.
Fill the form below to download the Case Study
